Citations (272)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Michela Roberto, Giulia Arrivi, Emanuela Pilozzi, Andrea Montori, Genoveffa Balducci, Paolo Mercantini, Andrea Laghi, Debora Ierinò, Martina Panebianco, Daniele Marinelli, Silverio Tomao, Paolo Marchetti & Federica Mazzuca. (2022) The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study. Cancer Management and Research 14, pages 1353-1369.
Read now
Read now
Shaohua Guo, Yumeng Ye, Xinyi Liu, Yuan Gong, Mingyan Xu, Lele Song & Hongyi Liu. (2021) Intra-Tumor Heterogeneity of Colorectal Cancer Necessitates the Multi-Regional Sequencing for Comprehensive Mutational Profiling. Cancer Management and Research 13, pages 9209-9223.
Read now
Read now
Fahimeh Kalbkhani, Ali Pirnejad, Sohrab Sam & Mohammad Reza Sam. (2021) The Safe Soluble Compound Dehydroascorbic Acid Inhibits Various Upstream and Downstream Effectors of PI3K and KRAS Signaling Pathways in Undruggable PIK3CA/KRAS-Mutant Colorectal Cancer Stem-Like Cells. Nutrition and Cancer 73:11-12, pages 2654-2664.
Read now
Read now
Xin Yi Wong, Andrew Qi Jun Lim, Qianyu Shen, John Whay Kuang Chia, Min Hoe Chew, Wah Siew Tan & Hwee-Lin Wee. (2020) Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment. Current Medical Research and Opinion 36:10, pages 1677-1686.
Read now
Read now
Luís Nunes, Kristine Aasebø, Lucy Mathot, Viktor Ljungström, Per-Henrik Edqvist, Magnus Sundström, Anca Dragomir, Per Pfeiffer, Adam Ameur, Fredrik Ponten, Artur Mezheyeuski, Halfdan Sorbye, Tobias Sjöblom & Bengt Glimelius. (2020) Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis. Acta Oncologica 59:4, pages 417-426.
Read now
Read now
Artur Mezheyeuski, Fredrik Ponten, Per-Henrik Edqvist, Magnus Sundström, Ulf Thunberg, Camilla Qvortrup, Per Pfeiffer, Halfdan Sorbye, Bengt Glimelius & Anca Dragomir. (2020) Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study. Acta Oncologica 59:3, pages 284-290.
Read now
Read now
Wei Du, Xu Zhang & Zhen Wan. (2019) miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN. OncoTargets and Therapy 12, pages 4897-4906.
Read now
Read now
Francesca Battaglin, Alberto Puccini, Selma Ahcene Djaballah & Heinz-Josef Lenz. (2019) The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer. Cancer Management and Research 11, pages 5911-5924.
Read now
Read now
Siavash Foroughi, Jeanne Tie, Peter Gibbs & Antony Wilks Burgess. (2019) Epidermal growth factor receptor ligands: targets for optimizing treatment of metastatic colorectal cancer. Growth Factors 37:5-6, pages 209-225.
Read now
Read now
Yingchi Yang, Dong Wang, Lan Jin, Guocong Wu, Zhigang Bai, Jin Wang, Hongwei Yao & Zhongtao Zhang. (2018) Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer. Cancer Management and Research 10, pages 3911-3929.
Read now
Read now
Bengt Glimelius. (2018) Forty-five years in oncology, 25 years with Acta Oncologica. Acta Oncologica 57:12, pages 1593-1598.
Read now
Read now
Eleonora Lai, Andrea Pretta, Valentino Impera, Stefano Mariani, Riccardo Giampieri, Laura Casula, Valeria Pusceddu, Pierpaolo Coni, Daniela Fanni, Marco Puzzoni, Laura Demurtas, Pina Ziranu, Gavino Faa & Mario Scartozzi. (2018) BRAF-mutant colorectal cancer, a different breed evolving. Expert Review of Molecular Diagnostics 18:6, pages 499-512.
Read now
Read now
Francesca Battaglin, Vincenzo Dadduzio, Francesca Bergamo, Chiara Manai, Marta Schirripa, Sara Lonardi, Vittorina Zagonel & Fotios Loupakis. (2017) Anti-EGFR monoclonal antibody panitumumab for the treatment of patients with metastatic colorectal cancer: an overview of current practice and future perspectives. Expert Opinion on Biological Therapy 17:10, pages 1297-1308.
Read now
Read now
Debora Basile, Silvio Ken Garattini, Marta Bonotto, Elena Ongaro, Mariaelena Casagrande, Monica Cattaneo, Valentina Fanotto, Elisa De Carlo, Fotios Loupakis, Federica Urbano, Francesca V. Negri, Nicoletta Pella, Marco Russano, Oronzo Brunetti, Mario Scartozzi, Daniele Santini, Nicola Silvestris, Andrea Casadei Gardini, Marco Puzzoni, Lorenzo Calvetti, Nadia Cardarelli & Giuseppe Aprile. (2017) Immunotherapy for colorectal cancer: where are we heading?. Expert Opinion on Biological Therapy 17:6, pages 709-721.
Read now
Read now
Simona Serratì, Simona De Summa, Brunella Pilato, Daniela Petriella, Rosanna Lacalamita, Stefania Tommasi & Rosamaria Pinto. (2016) Next-generation sequencing: advances and applications in cancer diagnosis. OncoTargets and Therapy 9, pages 7355-7365.
Read now
Read now
Shiven B Patel, David Gill & Ignacio Garrido-Laguna. (2016) Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer. OncoTargets and Therapy 9, pages 75-86.
Read now
Read now
Bengt Glimelius. (2016) Tell all the good news as soon as possible. Acta Oncologica 55:9-10, pages 1067-1068.
Read now
Read now
Bengt Glimelius. (2015) What’s new about Acta Oncologica for 2016?. Acta Oncologica 54:10, pages 1703-1705.
Read now
Read now
Dimitra Grapsa, Konstantinos Syrigos & Muhammad Wasif Saif. (2015) Bevacizumab in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy for first-line and maintenance treatment of metastatic colorectal cancer. Expert Review of Anticancer Therapy 15:11, pages 1267-1281.
Read now
Read now
Mario Scartozzi, Riccardo Giampieri, Giuseppe Aprile, Donatella Iacono, Daniele Santini, Emanuela dell’Aquila, Nicola Silvestris, Antonio Gnoni, Marta Bonotto, Marco Puzzoni, Laura Demurtas & Stefano Cascinu. (2015) The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors. Expert Review of Molecular Diagnostics 15:8, pages 979-987.
Read now
Read now
Bengt Glimelius. (2015) Adjuvant chemotherapy for patients with rectal cancer – will the controversy be resolved?. Acta Oncologica 54:4, pages 433-436.
Read now
Read now
Olav Dahl & Frank Pfeffer. (2015) Twenty-five years with adjuvant chemotherapy for colon cancer – a continuous evolving concept. Acta Oncologica 54:1, pages 1-4.
Read now
Read now
Articles from other publishers (250)
Jessica S. Thomas & Chanjuan Shi. 2024. Diagnostic Molecular Pathology. Diagnostic Molecular Pathology
339
358
.
Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu & Yueqiu Gao. (2023) Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC Cancer 23:1.
Crossref
Crossref
Md Sajedul Islam, Vinod Gopalan, Alfred K. Lam & Muhammad J.A. Shiddiky. (2023) Current advances in detecting genetic and epigenetic biomarkers of colorectal cancer. Biosensors and Bioelectronics 239, pages 115611.
Crossref
Crossref
Zaoqu Liu, Tian Duan, Yuyuan Zhang, Siyuan Weng, Hui Xu, Yuqing Ren, Zhenyu Zhang & Xinwei Han. (2023) Radiogenomics: a key component of precision cancer medicine. British Journal of Cancer 129:5, pages 741-753.
Crossref
Crossref
Thomas Lawler, Lisa Parlato & Shaneda Warren Andersen. (2023) Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review. Cancer Causes & Control.
Crossref
Crossref
Christian Tibor Josef Magyar, Yogesh K. Vashist, Deborah Stroka, Corina Kim-Fuchs, Martin D. Berger & Vanessa M. Banz. (2023) Heat shock protein 90 (HSP90) inhibitors in gastrointestinal cancer: where do we currently stand?—A systematic review. Journal of Cancer Research and Clinical Oncology 149:10, pages 8039-8050.
Crossref
Crossref
Mohamed E. Shaker, Hesham A.M. Gomaa, Mohamed A. Abdelgawad, Mohamed El-Mesery, Ahmed A. Shaaban & Sara H. Hazem. (2023) Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities. International Immunopharmacology 120, pages 110373.
Crossref
Crossref
Hoang Minh Cuong, Vu Hong Thang, Bui-Thi Thu Huong, Nguyen Thuan Loi & Nguyen Minh Duc. (2023)
KRAS
mutations and their associations with clinicopathological features and survival in Vietnamese non‑polyp colon cancer patients
. Molecular and Clinical Oncology 19:2.
Crossref
Crossref
Benjamin D. Booker, Sarah C. Markt, Fredrick R. Schumacher, Johnie Rose, Greg Cooper, J. Eva Selfridge & Siran M. Koroukian. (2023) Variation in KRAS/NRAS/BRAF-Mutation Status by Age, Sex, and Race/Ethnicity Among a Large Cohort of Patients with Metastatic Colorectal Cancer (mCRC). Journal of Gastrointestinal Cancer.
Crossref
Crossref
Fauzia Ullah, Ashwathy Balachandran Pillai, Najiullah Omar, Danai Dima & Seema Harichand. (2023) Early-Onset Colorectal Cancer: Current Insights. Cancers 15:12, pages 3202.
Crossref
Crossref
Kiruthiga Chandramohan, Devasahayam Jaya Balan, Kasi Pandima Devi, Seyed Fazel Nabavi, Sara Reshadat, Maryam Khayatkashani, Sepideh Mahmoodifar, Rosanna Filosa, Niloufar Amirkhalili, Soroush Pishvaei, Omolbanin Sargazi-Aval & Seyed Mohammad Nabavi. (2023) Short interfering RNA in colorectal cancer: is it wise to shoot the messenger?. European Journal of Pharmacology 949, pages 175699.
Crossref
Crossref
Li Ren, Dexiang Zhu, Jin Gu, Baoqing Jia, Jin Li, Xinyu Qin, Xishan Wang, Ruihua Xu, Yingjiang Ye, Suzhan Zhang, Zhongtao Zhang, Jianmin Xu & Jia Fan. (2023) Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023). Clinical Surgical Oncology 2:2, pages 100013.
Crossref
Crossref
Sebastian Cammann, Tobias Münchow, Arndt Vogel & Moritz Schmelzle. (2023) Rolle der Chirurgie in Zeiten der PräzisionsonkologieRole of surgery in times of precision oncology. Die Onkologie.
Crossref
Crossref
Omkar Desai & Rui Wang. (2023) HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma. Oncotarget 14:1, pages 439-443.
Crossref
Crossref
Wangyang Pu, Fengjiao Wang, Kai Li, Chungen Xing, Zhixiang Zhuang, Hui Wang, Huahui Bian, Rong Zhang & Li Xiao. (2023) Novel Method for Detection of PIK3CA Mutations in Circulating Tumor DNA of Patients with Colorectal Cancer. Applied Biochemistry and Biotechnology.
Crossref
Crossref
Jun Zhang, Jacob Croft & Alexander Le. (2023) Familial CCM Genes Might Not Be Main Drivers for Pathogenesis of Sporadic CCMs-Genetic Similarity between Cancers and Vascular Malformations. Journal of Personalized Medicine 13:4, pages 673.
Crossref
Crossref
Yun Zhong, Keli Yang, Xiusen Qin, Rui Luo & Hui Wang. (2023) Impact of Molecular Status on Cytoreductive Surgery for Peritoneal Metastases from Colorectal Cancer. Clinics in Colon and Rectal Surgery.
Crossref
Crossref
Tanja Mesti, Martina Rebersek & Janja Ocvirk. (2023)
The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1
st
line treatment of metastatic colorectal (mCRC) patients with
RAS
wild-type tumour (wt
RAS
) – a real- life data report 2013–2018
. Radiology and Oncology 57:1, pages 103-110.
Crossref
Crossref
Rajesh Kumar, Seetha Harilal, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Arun Kumar & Bijo Mathew. (2023) Urachal carcinoma: The journey so far and the road ahead. Pathology - Research and Practice 243, pages 154379.
Crossref
Crossref
Siran M. Koroukian, Benjamin D. Booker, Long Vu, Fredrick R. Schumacher, Johnie Rose, Gregory S. Cooper, J. Eva Selfridge & Sarah C. Markt. (2023) Receipt of Targeted Therapy and Survival Outcomes in Patients With Metastatic Colorectal Cancer. JAMA Network Open 6:1, pages e2250030.
Crossref
Crossref
Ambrose H. N. Wong, Brigette Ma & Rashid N. Lui. (2023) New developments in targeted therapy for metastatic colorectal cancer. Therapeutic Advances in Medical Oncology 15, pages 175883592211485.
Crossref
Crossref
Simon Haefliger, Katharina Marston, Ilaria Alborelli, Edouard-Jean Stauffer, Mathias Gugger, Philip M. Jermann, Sylvia Hoeller, Luigi Tornillo, Luigi M. Terracciano, Michel Bihl & Matthias S. Matter. (2023) Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics. Pathobiology 90:3, pages 166-175.
Crossref
Crossref
Angus J. Lloyd, Éanna J. Ryan, Simon M. Clifford, Roisin MacDermott, Áine Stakelum, Marta Climent, Kieran Sheahan, Rory Kennelly, Ann Hanly, Sean T. Martin, Desmond C. Winter & Stephen J. Skehan. (2023) Pilot radiogenomic evaluation of colorectal cancer - Are there preoperative radiological features of the dMMR phenotype?. The Royal College of Radiologists Open 1, pages 100003.
Crossref
Crossref
Po-Han Lin, Ling-Ming Tseng, Yi-Hsuan Lee, Shou-Tung Chen, Dah-Cherng Yeh, Ming-Shen Dai, Liang-Chih Liu, Ming-Yang Wang, Chiao Lo, Stanley Chang, Kien Thiam Tan, Shu-Jen Chen, Sung-Hsin Kuo & Chiun-Sheng Huang. (2022) Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders. Journal of the Formosan Medical Association 121:12, pages 2538-2547.
Crossref
Crossref
Ting Xue, Hui Peng, Qiaoling Chen, Manman Li, Shaofeng Duan & Feng Feng. (2022) A CT-Based Radiomics Nomogram in Predicting the Postoperative Prognosis of Colorectal Cancer: A Two-center Study. Academic Radiology 29:11, pages 1647-1660.
Crossref
Crossref
Seda EREN KESKİN, Eda GÜZDOLU, Nilüfer SERTDEMİR, Gülhan DEMİR, Deniz SÜNNETÇİ AKKOYUNLU, Devrim ÇABUK, Naci ÇİNE & Hakan SAVLI. (2022) The Mutation Profiles of K-RAS/N-RAS Genes in Metastatic Colorectal Cancer PatientsMetastatik Kolorektal Kanserli Hastalarda KRAS/NRAS Gen Mutasyon Profilleri. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi 8:3, pages 172-178.
Crossref
Crossref
Ryutaro Yasudome, Naohiko Seki, Shunichi Asai, Yusuke Goto, Yoshiaki Kita, Yuto Hozaka, Masumi Wada, Kan Tanabe, Tetsuya Idichi, Shinichiro Mori & Takao Ohtsuka. (2022) Molecular Pathogenesis of Colorectal Cancer: Impact of Oncogenic Targets Regulated by Tumor Suppressive miR-139-3p. International Journal of Molecular Sciences 23:19, pages 11616.
Crossref
Crossref
Jizhong Han, Huajiang Deng, Yu Xiong, Xiangguo Xia, Changshun Bao, Ligang Chen, Qin Zhao, Shunjie Zhong, Lilei Peng & Chuanhong Zhong. (2022) Reduced PTCH2 expression is associated with glioma development through its regulation of the PTEN/AKT signaling pathway. Biochemical and Biophysical Research Communications 627, pages 76-83.
Crossref
Crossref
Sharmin Chowdhury, Sheikh Joly Ferdous Ara, Shirazum Monira Mili, Tahani Momotaz, Md Maruf Ahmed Molla, Shaheda Anwar & Ahmed Abu Saleh. (2022) Mutational profile of KRAS, NRAS, BRAF, PIK3CA, and AKT1 genes in colorectal cancer patients in a tertiary care hospital, Dhaka. Advances in Cancer Biology - Metastasis 5, pages 100054.
Crossref
Crossref
Javier Vaquero, Allan Pavy, Ester Gonzalez-Sanchez, Mark Meredith, Ander Arbelaiz & Laura Fouassier. (2022) Genetic alterations shaping tumor response to anti-EGFR therapies. Drug Resistance Updates 64, pages 100863.
Crossref
Crossref
Hampig R Kourie, Fahad Ibnshamsah, Joseph Zouein, Nabih Naim, Salah Abbasi, Nasr Allahloubi, Manwar Al-Naqqash, Ashwaq Alolayan, Ahmed Alshehri, Nizar Bitar, Adda Bounedjar, Abdulaziz Al Farsi, Humaid El Shamsi, Ramy Ghali, Hassan Jaafar, Blaha Larbaoui, Mervat Mahrous, Hind Mrabti, Abdul Razzak Nweir, Mohamed Oukkal, Kakil Rasul, Mohsen Razavi, Rim Turfa, Sami Khatib & Ali Shamseddine. (2022) The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer. Future Oncology 18:24, pages 2733-2744.
Crossref
Crossref
Nabi Mousavi, Sarah Line Bring Truelsen, Simon Bernth‐Andersen, Anders Koch & Steffen Heegaard. (2022)
Mutation of
KRAS
in colorectal adenocarcinoma in Greenland
. APMIS 130:8, pages 493-497.
Crossref
Crossref
Nikolai A. Ognerubov & Elena N. Ezhova. (2022) Somatic mutations in colorectal cancer: regional experience. Consilium Medicum 24:5, pages 291-296.
Crossref
Crossref
Hafeez Afolabi, Salzihan Md Salleh, Zaidi Zakaria, Ch’ng Ewe Seng, Siti Norasikin Binti Mohd Nafil, Ahmad Aizat Bin Abdul Aziz, Yusuf Wada & Ahmad Irekeola. (2022) A Systematic Review and Meta-analysis on the Occurrence of Biomarker Mutation in Colorectal Cancer among the Asian Population. BioMed Research International 2022, pages 1-21.
Crossref
Crossref
Xueting Liu, Litao Huang, Menghan Liu & Zhu Wang. (2022) The Molecular Associations of Signet-Ring Cell Carcinoma in Colorectum: Meta-Analysis and System Review. Medicina 58:7, pages 836.
Crossref
Crossref
Kshama Gupta, Jeremy C. Jones, Virginea De Araujo Farias, Yuri Mackeyev, Pankaj K. Singh, Alfredo Quiñones-Hinojosa & Sunil Krishnan. (2022) Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma. Frontiers in Oncology 12.
Crossref
Crossref
Takuro Mizukami, Masaki Takahashi, Yu Sunakawa, Satoshi Yuki, Yoshinori Kagawa, Atsuo Takashima, Kyoko Kato, Hiroki Hara, Tadamichi Denda, Yoshiyuki Yamamoto, Manabu Shiozawa, Eiji Oki, Wataru Okamoto, Takayuki Yoshino & Takako Eguchi Nakajima. (2022) Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care Chemotherapy. Targeted Oncology 17:3, pages 343-353.
Crossref
Crossref
Faddy Kamel, Khadiga Eltarhoni, Pasha Nisar & Mikhail Soloviev. (2022) Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection. Cancers 14:8, pages 1889.
Crossref
Crossref
Sridhar Mishra, Swati Kumari, Pallavi Srivastava, Anshuman Pandey, Saumya Shukla & Nuzhat Husain. (2022) Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved. Pathology - Research and Practice 232, pages 153806.
Crossref
Crossref
Lei Pu & Peng Sun. (2022) The Systematic Analysis of Exercise Mechanism in Human Diseases. Genetics Research 2022, pages 1-9.
Crossref
Crossref
Hui Zhou, Zhongtao Liu, Yongxiang Wang, Xiaoyong Wen, Eric H. Amador, Liqin Yuan, Xin Ran, Li Xiong, Yuping Ran, Wei Chen & Yu Wen. (2022) Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
E. N. Telysheva, E. G. Shaikhaev & G. P. Snigireva. (2022) Mutational profile of KRAS-positive colorectal cancer. Siberian journal of oncology 21:1, pages 47-56.
Crossref
Crossref
Sarah Ouahoud, Rutger J. Jacobs, Ludmilla L. Kodach, Philip W. Voorneveld, Lukas J. A. C. Hawinkels, Nikki L. Weil, Britt van Vliet, Ron M. Herings, Lennart R. A. van der Burg, Tom van Wezel, Hans Morreau, Marije Slingerland, Esther Bastiaannet, Hein Putter & James C. H. Hardwick. (2021) Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4. British Journal of Cancer 126:2, pages 297-301.
Crossref
Crossref
Bashdar Mahmud Hussen, Sara Tharwat Abdullah, Abbas Salihi, Dana Khdr Sabir, Karzan R. Sidiq, Mohammed Fatih Rasul, Hazha Jamal Hidayat, Soudeh Ghafouri-Fard, Mohammad Taheri & Elena Jamali. (2022) The emerging roles of NGS in clinical oncology and personalized medicine. Pathology - Research and Practice 230, pages 153760.
Crossref
Crossref
Lubna Therachiyil, Anjana Anand, Abdullah Azmi, Ajaz Bhat, Hesham M. Korashy & Shahab Uddin. (2022) Role of RAS signaling in ovarian cancer. F1000Research 11, pages 1253.
Crossref
Crossref
Ankit Srivastava, Sandhya Rai, Deepa Bisht, Manisha Sachan, Bimal Prasad Jit & Sameer Srivastava. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
361
391
.
Muhammad Ikram & Zia Uddin. 2022. Cancer Biomarkers in Diagnosis and Therapeutics. Cancer Biomarkers in Diagnosis and Therapeutics
177
200
.
Burcin Pehlivanoglu & S. Mehtat Unlu. 2022. Biomarkers in Carcinoma of Unknown Primary. Biomarkers in Carcinoma of Unknown Primary
165
199
.
Julaluck Promsorn, Payia Chadbunchachai, Kulyada Somsap, Krisada Paonariang, Prakasit Sa-ngaimwibool, Chaiwat Apivatanasiri, Rita Maria Lahoud & Mukesh Harisinghani. (2021) Imaging features associated with survival outcomes among colorectal cancer patients with and without KRAS mutation. Egyptian Journal of Radiology and Nuclear Medicine 52:1.
Crossref
Crossref
Iris van 't Erve, Nina J. Wesdorp, Jamie E. Medina, Leonardo Ferreira, Alessandro Leal, Joost Huiskens, Karen Bolhuis, Jan-Hein T. M. van Waesberghe, Rutger-Jan Swijnenburg, Daan van den Broek, Victor E. Velculescu, Geert Kazemier, Cornelis J. A. Punt, Gerrit A. Meijer & Remond J. A. Fijneman. (2021)
KRAS
A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases
. JCO Precision Oncology:5, pages 1758-1767.
Crossref
Crossref
Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Remus Iulian Nica, Maria Greabu, Alexandra Ripszky Totan & Mariana Jinga. (2021) Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?. International Journal of Molecular Sciences 22:19, pages 10260.
Crossref
Crossref
Ioannis A. Voutsadakis. (2021) The Landscape of PIK3CA Mutations in Colorectal Cancer. Clinical Colorectal Cancer 20:3, pages 201-215.
Crossref
Crossref
Hadeer Abosalem, Shahenda Mahgoub, Mohamed Emara, Nahla Kotb & Sameh Soror. (2021) Interrupted Crosstalk between Natural Killer Cells and Anti-epidermal Growth Factor Receptor: A Possible Role in Hepatocellular Carcinoma Treatment Failure. Current Cancer Drug Targets 21:7, pages 601-607.
Crossref
Crossref
Nabi Mousavi. (2021)
Characterization of
in vitro
3D cultures
. APMIS 129:S142, pages 1-30.
Crossref
Crossref
Vicenç Ruiz de Porras, Laura Layos & Eva Martínez-Balibrea. (2021) Curcumin: A therapeutic strategy for colorectal cancer?. Seminars in Cancer Biology 73, pages 321-330.
Crossref
Crossref
Karen Bolhuis, Iris van 't Erve, Clinton Mijnals, Pien M. Delis – Van Diemen, Joost Huiskens, Aysun Komurcu, Marta Lopez-Yurda, Daan van den Broek, Rutger-Jan Swijnenburg, Gerrit A. Meijer, Cornelis J.A. Punt & Remond J.A. Fijneman. (2021) Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases. EBioMedicine 70, pages 103498.
Crossref
Crossref
Bengt Glimelius, Sebastian Stintzing, John Marshall, Takayuki Yoshino & Aimery de Gramont. (2021) Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone. Cancer Treatment Reviews 98, pages 102218.
Crossref
Crossref
María González-González, María Laura Gutiérrez, José María Sayagués, Luis Muñoz-Bellvís & Alberto Orfao. (2021) Genomic profiling of sporadic liver metastatic colorectal cancer. Seminars in Cancer Biology 71, pages 98-108.
Crossref
Crossref
Sherry Yueh-Hsia Chiu, Chia-Hsun Hsieh, Jeng-Fu You, Po-Yu Chu, Hsin-Yuan Hung, Pao-Hsien Chu & Min-Hsien Wu. (2021) Enhancing Prediction Performance by Add-On Combining Circulating Tumor Cell Count, CD45neg EpCAMneg Cell Count on Colorectal Cancer, Advance, and Metastasis. Cancers 13:11, pages 2521.
Crossref
Crossref
Jun-Zhen Fan, Gao-Fei Wang, Xue-Bin Cheng, Zhou-Huan Dong, Xin Chen, Yu-Jiao Deng & Xin Song. (2021)
Relationship between mismatch repair protein,
RAS
,
BRAF
,
PIK3CA
gene expression and clinicopathological characteristics in elderly colorectal cancer patients
. World Journal of Clinical Cases 9:11, pages 2458-2468.
Crossref
Crossref
Yuan-Tzu Lan, Shih-Ching Chang, Pei-Ching Lin, Chun-Chi Lin, Hung-Hsin Lin, Sheng-Chieh Huang, Chien-Hsing Lin, Wen-Yi Liang, Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang & Jen-Kou Lin. (2021) Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal Cancer. Cancers 13:8, pages 1883.
Crossref
Crossref
Clement Chung. (2021) Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation. Journal of Oncology Pharmacy Practice, pages 107815522110055.
Crossref
Crossref
Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Joan Maurel, Rocio Garcia-Carbonero, Jaume Capdevila, Laura G-Pastrián, Marta Mendiola, Cristina Peña, Rocío López-Vacas, Miriam Cuatrecasas, Pilar García-Alfonso, Ricardo Ramos-Ruiz, Carlos Llorens, Ismael Ghanem, Carles Conill, Victoria Heredia-Soto, Ángel Campos-Barros, Juan Ángel Fresno Vara & Jaime Feliu. (2021) Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab. Scientific Reports 11:1.
Crossref
Crossref
Junhao Tu, Zongxi Yao, Wenqing Wu, Jianxiang Ju, Yinkai Xu & Yulin Liu. (2021) Perineural Invasion Is a Strong Prognostic Factor but Not a Predictive Factor of Response to Adjuvant Chemotherapy in Node-Negative Colon Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Kimio Yonesaka. (2021) HER2-/HER3-Targeting Antibody—Drug Conjugates for Treating Lung and Colorectal Cancers Resistant to EGFR Inhibitors. Cancers 13:5, pages 1047.
Crossref
Crossref
Xiang Chen, Jiayu Sun, Xue Wang, Yumeng Yuan, Leshan Cai, Yanxuan Xie, Zhiqiang Fan, Kaixi Liu & Xiaoyang Jiao. (2021) A Meta-Analysis of Proteomic Blood Markers of Colorectal Cancer. Current Medicinal Chemistry 28:6, pages 1176-1196.
Crossref
Crossref
Idris Babat, Hayri Polat, Rıza Umar Gursu, Yagmur Bashan, Ali Kırık, Hasan Bektas, Serkan Sarı & Çiğdem Usul Afşar. (2021) The effect of mutation status, pathological features and tumor location on prognosis ın patients with colorectal cancer. Revista da Associação Médica Brasileira 67:2, pages 185-189.
Crossref
Crossref
Xiao-na Chang, Fu-mei Shang, Hong-yu Jiang, Chen Chen, Zhe-yan Zhao, Sheng-he Deng, Jun Fan, Xiao-chuan Dong, Ming Yang, Yan Li, Kai-lin Cai, Li Liu, Hong-li Liu & Xiu Nie. (2021) Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China. Current Medical Science 41:1, pages 118-126.
Crossref
Crossref
Shuang Zhao, Ni Sun, Xi Yuan, Zetian Shen, Xixu Zhu & Jing Li. (2021) Genetic analysis of rapidly progressing esophageal squamous cell carcinoma. Medicine 100:9, pages e24462.
Crossref
Crossref
Chandramohan Kiruthiga & Kasi Pandima Devi. 2021. Nutraceuticals and Cancer Signaling. Nutraceuticals and Cancer Signaling
11
36
.
Vincenzo Formica, Jessica Lucchetti, Elena Doldo, Silvia Riondino, Cristina Morelli, Renato Argirò, Nicola Renzi, Daniele Nitti, Antonella Nardecchia, Emanuela Dell’Aquila, Patrizia Ferroni, Fiorella Guadagni, Giampiero Palmieri, Augusto Orlandi & Mario Roselli. (2020) Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases. Journal of Clinical Medicine 10:1, pages 87.
Crossref
Crossref
Qianxin Luo, Dianke Chen, Xinjuan Fan, Xinhui Fu, Tenghui Ma & Daici Chen. (2020) KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report. Translational Oncology 13:12, pages 100874.
Crossref
Crossref
Iris van 't Erve, Marjolein J.E. Greuter, Karen Bolhuis, Daan C.L. Vessies, Alessandro Leal, Geraldine R. Vink, Daan van den Broek, Victor E. Velculescu, Cornelis J.A. Punt, Gerrit A. Meijer, Veerle M.H. Coupé & Remond J.A. Fijneman. (2020) Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal Cancer. The Journal of Molecular Diagnostics 22:12, pages 1430-1437.
Crossref
Crossref
Roya Sarkhosh-Inanlou, Mehdi Imani & Mohammad Reza Sam. (2020) The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal. Biomedicine & Pharmacotherapy 132, pages 110807.
Crossref
Crossref
Julie G. Fisher, David Tait, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat, Julian C. Schink, Ricardo H. Alvarez, Dan Veljovich, Timothy L. Cannon, Pamela A. Crilley, Theodore Pollock, Carmen J. Calfa, Tareq Al Baghdadi, Ramya Thota, Nicole Fleming, Jared A. Cotta, Andrew L. Rygiel, Sasha L. Warren & Richard L. Schilsky. (2020) Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. Targeted Oncology 15:6, pages 733-741.
Crossref
Crossref
Izuma Nakayama, Toru Hirota & Eiji Shinozaki. (2020) BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation. Cancers 12:11, pages 3236.
Crossref
Crossref
Alessandro Ottaiano, Stefania Scala, Nicola Normanno, Gerardo Botti, Fabiana Tatangelo, Annabella Di Mauro, Monica Capozzi, Sergio Facchini, Salvatore Tafuto & Guglielmo Nasti. (2020) Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients. Applied Immunohistochemistry & Molecular Morphology 28:10, pages 755-760.
Crossref
Crossref
Shiyu Chen, Zhiwei He, Changhao Zhu, Yanqing Liu, Lin Li, Lu Deng, Jun Wang, Chao Yu & Chengyi Sun. (2020) TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT–GSK-3β–β-Catenin Signaling Pathway. Frontiers in Oncology 10.
Crossref
Crossref
Ozkan Kanat, Hulya Ertas & Burcu Caner. (2020)
Contemporary treatment approaches for metastatic colorectal cancer driven by
BRAF
V600 mutations
. World Journal of Gastrointestinal Oncology 12:10, pages 1080-1090.
Crossref
Crossref
Akihisa Hidaka, Tabitha A. Harrison, Yin Cao, Lori C. Sakoda, Richard Barfield, Marios Giannakis, Mingyang Song, Amanda I. Phipps, Jane C. Figueiredo, Syed H. Zaidi, Amanda E. Toland, Efrat L. Amitay, Sonja I. Berndt, Ivan Borozan, Andrew T. Chan, Steven Gallinger, Marc J. Gunter, Mark A. Guinter, Sophia Harlid, Heather Hampel, Mark A. Jenkins, Yi Lin, Victor Moreno, Polly A. Newcomb, Reiko Nishihara, Shuji Ogino, Mireia Obón-Santacana, Patrick S. Parfrey, John D. Potter, Martha L. Slattery, Robert S. Steinfelder, Caroline Y. Um, Xiaoliang Wang, Michael O. Woods, Bethany Van Guelpen, Stephen N. Thibodeau, Michael Hoffmeister, Wei Sun, Li Hsu, Daniel D. Buchanan, Peter T. Campbell & Ulrike Peters. (2020) Intake of Dietary Fruit, Vegetables, and Fiber and Risk of Colorectal Cancer According to Molecular Subtypes: A Pooled Analysis of 9 Studies. Cancer Research 80:20, pages 4578-4590.
Crossref
Crossref
Ana Lídia Ferreira Neves, Laura Elisabete Ribeiro Barbosa & João Paulo Meireles de Araújo Teixeira. (2020) Prognosis in colorectal cancer beyond TNM. Journal of Coloproctology 40:4, pages 404-411.
Crossref
Crossref
Bohuslava Vaňková, Tomáš Vaněček, Nikola Ptáková, Veronika Hájková, Martin Dušek, Michael Michal, Peter Švajdler, Ondřej Daum, Magdaléna Daumová, Michal Michal, Roman Mezencev & Marián Švajdler. (2020)
Targeted next generation sequencing of
MLH1
‐deficient,
MLH1
promoter hypermethylated, and
BRAF
/
RAS
‐wild‐type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions
. Genes, Chromosomes and Cancer 59:10, pages 562-568.
Crossref
Crossref
Adrian A. Negreros-Osuna, Anushri Parakh, Ryan B. CorcoranAli Pourvaziri, Avinash KambadakoneDavid P. RyanDushyant V. Sahani. (2020)
Radiomics Texture Features in Advanced Colorectal Cancer: Correlation with
BRAF
Mutation and 5-year Overall Survival
. Radiology: Imaging Cancer 2:5, pages e190084.
Crossref
Crossref
A. A. Rosenkranz & T. A. Slastnikova. (2020) Epidermal Growth Factor Receptor: Key to Selective Intracellular Delivery. Biochemistry (Moscow) 85:9, pages 967-993.
Crossref
Crossref
Astrid Lièvre, Christelle de la Fouchardière, Emmanuelle Samalin, Stéphane Benoist, Jean-Marc Phelip, Thierry André & Gérard Lledo. (2020) Cancers colorectaux avec mutation V600E de BRAF : où en sommes-nous ?. Bulletin du Cancer 107:9, pages 881-895.
Crossref
Crossref
Pau Riera, Benjamín Rodríguez-Santiago, Adriana Lasa, Lidia Gonzalez-Quereda, Berta Martín, Juliana Salazar, Ana Sebio, Anna C. Virgili, Jordi Minguillón, Cristina Camps, Jordi Surrallés & David Páez. (2020) Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients. Cancers 12:8, pages 2245.
Crossref
Crossref
Syed H. Zaidi, Tabitha A. Harrison, Amanda I. Phipps, Robert Steinfelder, Quang M. Trinh, Conghui Qu, Barbara L. Banbury, Peter Georgeson, Catherine S. Grasso, Marios Giannakis, Jeremy B. Adams, Elizabeth Alwers, Efrat L. Amitay, Richard T. Barfield, Sonja I. Berndt, Ivan Borozan, Hermann Brenner, Stefanie Brezina, Daniel D. Buchanan, Yin Cao, Andrew T. Chan, Jenny Chang-Claude, Charles M. Connolly, David A. Drew, Alton Brad FarrisIIIIII, Jane C. Figueiredo, Amy J. French, Charles S. Fuchs, Levi A. Garraway, Steve Gruber, Mark A. Guinter, Stanley R. Hamilton, Sophia Harlid, Lawrence E. Heisler, Akihisa Hidaka, John L. Hopper, Wen-Yi Huang, Jeroen R. Huyghe, Mark A. Jenkins, Paul M. Krzyzanowski, Mathieu Lemire, Yi Lin, Xuemei Luo, Elaine R. Mardis, John D. McPherson, Jessica K. Miller, Victor Moreno, Xinmeng Jasmine Mu, Reiko Nishihara, Nickolas Papadopoulos, Danielle Pasternack, Michael J. Quist, Adilya Rafikova, Emma E. G. Reid, Eve Shinbrot, Brian H. Shirts, Lincoln D. Stein, Cherie D. Teney, Lee Timms, Caroline Y. Um, Bethany Van Guelpen, Megan Van Tassel, Xiaolong Wang, David A. Wheeler, Christina K. Yung, Li Hsu, Shuji Ogino, Andrea Gsur, Polly A. Newcomb, Steven Gallinger, Michael Hoffmeister, Peter T. Campbell, Stephen N. Thibodeau, Wei Sun, Thomas J. Hudson & Ulrike Peters. (2020) Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival. Nature Communications 11:1.
Crossref
Crossref
Hiroya Taniguchi, Keisuke Uehara, Goro Nakayama, Hiroshi Nakayama, Toshisada Aiba, Norifumi Hattori, Masato Kataoka, Yasuyuki Nakano, Yoshihisa Kawase, Osamu Okochi, Hiroshi Matsuoka, Setsuo Utsunomiya, Eiji Sakamoto, Yoshinori Mori, Shinichi Umeda, Toshio Shikano, Koji Komori, Masahiro Tajika, Shigenori Kadowaki, Kei Muro & Yasushi Yatabe. (2020) Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan. Translational Oncology 13:7, pages 100786.
Crossref
Crossref
Stanislav John. (2020) Current perspective on the treatment of advanced/metastatic colorectal cancer. Onkologie 14:3, pages 126-130.
Crossref
Crossref
Qing-Hai Li, Ying-Zhao Wang, Jian Tu, Chu-Wei Liu, Yu-Jie Yuan, Run Lin, Wei-Ling He, Shi-Rong Cai, Yu-Long He & Jin-Ning Ye. (2020) Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance. Gastroenterology Report 8:3, pages 179-191.
Crossref
Crossref
Zi-Nan Li, Lin Zhao, Li-Feng Yu & Min-Jie Wei. (2020) BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy. Gastroenterology Report 8:3, pages 192-205.
Crossref
Crossref
Raquel Alcaraz, Pilar Muñiz, Mónica Cavia, Óscar Palacios, Katia G. Samper, Rubén Gil-García, Alondra Jiménez-Pérez, Javier García-Tojal & Carlos García-Girón. (2020) Thiosemicarbazone-metal complexes exhibiting cytotoxicity in colon cancer cell lines through oxidative stress. Journal of Inorganic Biochemistry 206, pages 110993.
Crossref
Crossref
Katherine A. Johnson, Rebecca A. DeStefanis, Philip B. Emmerich, Patrick T. Grogan, Jeremy D. Kratz, Sarbjeet K. Makkar, Linda Clipson & Dustin A. Deming. (2020) Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection. Current Treatment Options in Oncology 21:5.
Crossref
Crossref
François Hafezi & Danielle Perez Bercoff. (2020) The Solo Play of TERT Promoter Mutations. Cells 9:3, pages 749.
Crossref
Crossref
Tuva Høst Brunsell, Anita Sveen, Bjørn Atle Bjørnbeth, Bård I. Røsok, Stine Aske Danielsen, Kristoffer Watten Brudvik, Kaja C.G. Berg, Bjarne Johannessen, Vanja Cengija, Andreas Abildgaard, Marianne Grønlie Guren, Arild Nesbakken & Ragnhild A. Lothe. (2020) High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases. Clinical Colorectal Cancer 19:1, pages e26-e47.
Crossref
Crossref
Lauren C. Bylsma, Christina Gillezeau, Tamer A. Garawin, Michael A. Kelsh, Jon P. Fryzek, Laura Sangaré & Kimberly A. Lowe. (2019) Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis. Cancer Medicine 9:3, pages 1044-1057.
Crossref
Crossref
N. G. Vasilchenko, D. S. Kutilin, N. N. Timoshkina, D. S. Potyomkin, S. I. Poluektov, M. A. Gusareva, N. G. Kosheleva, K. I. Soldatova, A. Y. Maksimov, O. I. Kit & Yu. S. Sidorenko. (2020) MODERN RADIOTHERAPY REGIMENS AND BIOMARKERS OF RADIORESISTANT RECTAL TUMOR CELLS. Siberian journal of oncology 18:6, pages 105-113.
Crossref
Crossref
Sangeetha Prabhakaran, Joseph Leong, Nicholas J. Petrelli & Vijay P. Khatri. (2020) Precision Medicine in Colorectal Surgery. Surgical Oncology Clinics of North America 29:1, pages 23-34.
Crossref
Crossref
Zhaoqian Liu, Chenxue Mao & Jiye Yin. 2020. Pharmacogenomics in Precision Medicine. Pharmacogenomics in Precision Medicine
55
82
.
Khalid El Bairi, Csongor Lengyel, Antonio Marra & Said Afqir. 2020. Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing. Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing
29
71
.
Renaud Sabatier, Marc Lopez, Arnaud Guille, Emilien Billon, Nadine Carbuccia, Séverine Garnier, José Adelaide, Jean-Marc Extra, Maria-Antonietta Cappiello, Emmanuelle Charafe-Jauffret, Jihane Pakradouni, Patrice Viens, Anthony Gonçalves, Max Chaffanet, Daniel Birnbaum & François Bertucci. (2019)
High Response to Cetuximab in a Patient With
EGFR
-Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer
. JCO Precision Oncology:3, pages 1-8.
Crossref
Crossref
Yuankai Shi, Jin Li, Jianming Xu, Yan Sun, Liwei Wang, Ying Cheng, Wei Liu, Guoping Sun, Yigui Chen, Li Bai, Yiping Zhang, Xiaohui He, Yi Luo, Zhehai Wang, Yunpeng Liu, Qiang Yao, Yuhong Li, Shukui Qin, Xiaohua Hu, Feng Bi, Rongsheng Zheng & Xuenong Ouyang. (2019)
CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in
KRAS
wild‐type metastatic colorectal cancer patients: promising findings from a prospective, open‐label, randomized, phase III trial
. Cancer Communications 39:1, pages 1-13.
Crossref
Crossref
Amal Idrissi Janati, Igor Karp, Hisham Sabri & Elham Emami. (2019) Is a fusobacterium nucleatum infection in the colon a risk factor for colorectal cancer?: a systematic review and meta-analysis protocol. Systematic Reviews 8:1.
Crossref
Crossref
Rafael Pulido, Janire Mingo, Ayman Gaafar, Caroline E. Nunes-Xavier, Sandra Luna, Leire Torices, Javier C. Angulo & José I. López. (2019) Precise Immunodetection of PTEN Protein in Human Neoplasia. Cold Spring Harbor Perspectives in Medicine 9:12, pages a036293.
Crossref
Crossref
Weiguang Qiang, Qinqin WuXuefeng Ni, Chu Zhang & Jiemin Zhao. (2019) Emergence of KRAS p.G13D mutation and acquired resistance to cetuximab in colorectal cancer with vulvar metastasis. Medicine 98:50, pages e18423.
Crossref
Crossref
Lisa Salvatore, Maria Alessandra Calegari, Fotios Loupakis, Matteo Fassan, Brunella Di Stefano, Maria Bensi, Emilio Bria & Giampaolo Tortora. (2019) PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target. Cancers 11:11, pages 1765.
Crossref
Crossref
Tsung-Jen Lin, Kuo-Chu Lai, An-Sheng Lee, Chien-Hsin Chang, Chiung-Lin Liu & Ching-Hu Chung. (2019) Novel Antrodia cinnamomea Extract Reduced Cancer Stem-Like Phenotype Changes and Resensitized KRAS-Mutant Colorectal Cancer via a MicroRNA-27a Pathway. Cancers 11:11, pages 1657.
Crossref
Crossref
Titto Augustine, Radhashree Maitra, Jinghang Zhang, Jay Nayak & Sanjay Goel. (2019) Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib. Investigational New Drugs 37:5, pages 948-960.
Crossref
Crossref
Wolfgang Eisterer & Gerald Prager. (2019) Chemotherapy, Still an Option in the Twenty-First Century in Metastatic Colorectal Cancer?. CardioVascular and Interventional Radiology 42:9, pages 1213-1220.
Crossref
Crossref
Hui Chang, Guan‐Nan Wang & Ya‐Lan Tao. (2019) The expression of long noncoding RNA CRCAL‐3 in colorectal cancer and its impacts on cell proliferation and migration. Journal of Cellular Biochemistry 120:9, pages 15369-15377.
Crossref
Crossref
Kaoru Onidani, Hirokazu Shoji, Takahiko Kakizaki, Seiichi Yoshimoto, Shinobu Okaya, Nami Miura, Shoichi Sekikawa, Koh Furuta, Chwee Teck Lim, Takahiko Shibahara, Narikazu Boku, Ken Kato & Kazufumi Honda. (2019)
Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor
DNA
. Cancer Science 110:8, pages 2590-2599.
Crossref
Crossref
Elena Elez, Carles Pericay, Manuel Valladares-Ayerbes, Inmaculada Bando, Maria Jose Safont, Javier Gallego, Cristina Grávalos, Antonio Arrivi, Alfredo Carrato, Verónica Conde, Maria José Ortiz, Carlos López, Beatriz Alonso, Inmaculada Ruiz de Mena, Eduardo Díaz-Rubio, Josep Tabernero & Enrique Aranda. (2019) A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients. British Journal of Cancer 121:5, pages 378-383.
Crossref
Crossref
Yuan Feng, Yuan Zhang, Di Zhou, Gang Chen & Ning Li. (2019) MicroRNAs, intestinal inflammatory and tumor. Bioorganic & Medicinal Chemistry Letters 29:16, pages 2051-2058.
Crossref
Crossref
Fatima De Palma, Valeria D’Argenio, Jonathan Pol, Guido Kroemer, Maria Maiuri & Francesco Salvatore. (2019) The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer. Cancers 11:7, pages 1017.
Crossref
Crossref
Bogdan Badic, Mathieu Hatt, Stephanie Durand, Catherine Le Jossic-Corcos, Brigitte Simon, Dimitris Visvikis & Laurent Corcos. (2019) Radiogenomics-based cancer prognosis in colorectal cancer. Scientific Reports 9:1.
Crossref
Crossref
Toru Beppu, Itaru Endo, Irinel Popescu, Takayuki Yoshino, Shin Kobayashi, Junichi Shindoh, Etsuro Hatano, Katsunori Imai, Motohide Shimazu, Mitsuo Shimada & Hideo Baba. (2019) Multidisciplinary Treatment of Liver Metastasis from Colorectal Cancer to Create Novel Evidences大腸癌肝転移に対する集学的治療―新たなエビデンスの創出をめざして. The Japanese Journal of Gastroenterological Surgery 52:7, pages 390-403.
Crossref
Crossref
Sarah Wedden, Keith Miller, Ian M. Frayling, Teresa Thomas, Alina Chefani, Karolina Miller, Angela Hamblin, Jenny C. Taylor & Corrado D’Arrigo. (2019) Colorectal Cancer Stratification in the Routine Clinical Pathway: A District General Hospital Experience. Applied Immunohistochemistry & Molecular Morphology 27:6, pages e54-e62.
Crossref
Crossref
H. Reis & T. Szarvas. (2019) Urachal cancer—current concepts of a rare cancerDas Urachuskarzinom – aktuelle Konzepte einer seltenen Tumorerkrankung. Der Pathologe 40:S1, pages 31-39.
Crossref
Crossref
Arlou Angeles, Ryan Yu, Eva Cutiongco‑De la Paz & Reynaldo Garcia. (2019) Phenotypic characterization of the novel, non‑hotspot oncogenic KRAS mutants E31D and E63K. Oncology Letters.
Crossref
Crossref
Barbora Vanova, Michal Kalman, Karin Jasek, Ivana Kasubova, Tatiana Burjanivova, Anna Farkasova, Peter Kruzliak, Dietrich Busselberg, Lukas Plank & Zora Lasabova. (2019) Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer. Clinical and Experimental Medicine 19:2, pages 219-224.
Crossref
Crossref
Tan, Bai, Saintigny & Darido. (2019) mTOR Signalling in Head and Neck Cancer: Heads Up. Cells 8:4, pages 333.
Crossref
Crossref
Matthew ScarlottaCem SimsekAmy K. Kim. (2019) Liquid Biopsy in Solid Malignancy. Genetic Testing and Molecular Biomarkers 23:4, pages 284-296.
Crossref
Crossref
Georgios A Margonis, Martin E Kreis, Christopher L Wolfgang & Matthew J Weiss. (2019) Mutation status and surgical selection. Journal of Surgical Oncology 119:5, pages 616-622.
Crossref
Crossref
Martina Rebersek, Tanja Mesti, Marko Boc & Janja Ocvirk. (2019) Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients. Radiology and Oncology 53:1, pages 85-95.
Crossref
Crossref
Weihua Li, Tian Qiu, Lei Guo, Jianming Ying & Aiping Zhou. (2019) NGS-based oncogenic mutations analysis in advanced colorectal cancer patients improves targeted therapy prediction. Pathology - Research and Practice 215:3, pages 483-489.
Crossref
Crossref
Lee-Jen Luu & Timothy J. Price. 2019. Advances in the Molecular Understanding of Colorectal Cancer. Advances in the Molecular Understanding of Colorectal Cancer.
Anuratha Sakthianandeswaren, Polly Sabljak, Meg J. Elliott, Michelle Palmieri & Oliver M. Sieber. 2019. Advances in the Molecular Understanding of Colorectal Cancer. Advances in the Molecular Understanding of Colorectal Cancer.
Matthew Burge, Timothy Price & Christos S. Karapetis. (2019) First‐line therapy for metastatic colorectal cancer: Current perspectives and future directions. Asia-Pacific Journal of Clinical Oncology 15:S1, pages 3-14.
Crossref
Crossref
Jinghu He, Junjie Xing, Xiaohong Yang, Chenxin Zhang, Yixiang Zhang, Hao Wang, Xiaodong Xu, Hantao Wang, Yi Cao, Haonan Xu, Chuansen Zhang, Chen Wang & Enda Yu. (2019) Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration. Chemotherapy 64:3, pages 146-154.
Crossref
Crossref
Alexandre A. B. A. da Costa, Felipe D’Almeida Costa, Daniel Vilarim Araújo, Marcos Pedro Guedes Camandaroba, Victor Hugo Fonseca de Jesus, Audrey Oliveira, Ana Caroline Fonseca Alves, Carlos Stecca, Larissa Machado, Andrea Cruz Feraz de Oliveira, Thiago Bueno de Oliveira, Ulisses Ribaldo Nicolau & Vladmir Cláudio Cordeiro de Lima. (2018) The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma. Medical Oncology 36:1.
Crossref
Crossref
Connull Leslie, M. Priyanthi Kumarasinghe & Ian Brown. 2019. Endoscopic Biopsy Interpretation. Endoscopic Biopsy Interpretation
299
309
.
Mandana Kamgar & W. Michael Korn. 2019. Textbook of Gastrointestinal Oncology. Textbook of Gastrointestinal Oncology
613
631
.
Francesco Damin, Silvia Galbiati, Nadia Soriani, Valentina Burgio, Monica Ronzoni, Maurizio Ferrari & Marcella Chiari. (2018) Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients. PLOS ONE 13:12, pages e0207876.
Crossref
Crossref
Ellen G. Engelhardt, Dóra Révész, Hans J. Tamminga, Cornelis J. A. Punt, Miriam Koopman, Bregje D. Onwuteaka-Philipsen, Ewout W. Steyerberg, Henrica C. W. de Vet & Veerle M. H. Coupé. (2018) Inventory of oncologists’ unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer. BMC Medical Informatics and Decision Making 18:1.
Crossref
Crossref
Abdulrahman Alhumaid, Zeyad AlYousef, Haafiz A. Bakhsh, Saleh AlGhamdi & Mohammad Azhar Aziz. (2018) Emerging paradigms in the treatment of liver metastases in colorectal cancer. Critical Reviews in Oncology/Hematology 132, pages 39-50.
Crossref
Crossref
Jeremy D. Shapiro, Subotheni Thavaneswaran, Craig R. Underhill, Kristy P. Robledo, Christos S. Karapetis, Fiona L. Day, Louise M. Nott, Michael Jefford, Lorraine A. Chantrill, Nick Pavlakis, Niall C. Tebbutt, Timothy. J. Price, Mustafa Khasraw, Guy A. Van Hazel, Paul M. Waring, Sabine Tejpar, John Simes, Val J. Gebski, Jayesh Desai & Eva Segelov. (2018) Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. Clinical Colorectal Cancer 17:4, pages 313-319.
Crossref
Crossref
H. Reis & T. Szarvas. (2018) Das Urachuskarzinom – aktuelle Konzepte einer seltenen TumorerkrankungUrachal cancer – current concepts of a rare cancer (German version). Der Pathologe 39:S2, pages 291-300.
Crossref
Crossref
Ozkan Kanat, Hulya Ertas & Burcu Caner. (2018) Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status. World Journal of Clinical Cases 6:11, pages 418-425.
Crossref
Crossref
Jasmine A Luzum & Jason C Cheung. (2018) Does cardiology hold pharmacogenetics to an inconsistent standard? A comparison of evidence among recommendations. Pharmacogenomics 19:15, pages 1203-1216.
Crossref
Crossref
Simon A Joosse, François-Régis Souche, Anna Babayan, Christin Gasch, Ron M Kerkhoven, Jeanne Ramos, Jean-Michel Fabre, Sabine Riethdorf, Alexandra König, Harriet Wikman, Catherine Alix-Panabières & Klaus Pantel. (2018) Chromosomal Aberrations Associated with Sequential Steps of the Metastatic Cascade in Colorectal Cancer Patients. Clinical Chemistry 64:10, pages 1505-1512.
Crossref
Crossref
Nitin Udar, Catherine Lofton-Day, Jun Dong, Darcy Vavrek, A. Scott Jung, Kristen Meier, Anita Iyer, Ryan Slaughter, Karen Gutekunst, Bruce A. Bach, Marc Peeters & Jean-Yves Douillard. (2018) Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study. Journal of Cancer Research and Clinical Oncology 144:10, pages 2001-2010.
Crossref
Crossref
Henning Reis, Kristan E. van der Vos, Christian Niedworok, Thomas Herold, Orsolya Módos, Attila Szendrői, Thomas Hager, Marc Ingenwerth, Daniël J. Vis, Mark A. Behrendt, Jeroen de Jong, Michiel S. van der Heijden, Benoit Peyronnet, Romain Mathieu, Marcel Wiesweg, Jason Ablat, Krzysztof Okon, Yuri Tolkach, David Keresztes, Nikolett Nagy, Felix Bremmer, Nadine T. Gaisa, Piotr Chlosta, Joerg Kriegsmann, Ilona Kovalszky, József Timar, Glen Kristiansen, Heinz‐Joachim Radzun, Ruth Knüchel, Martin Schuler, Peter C. Black, Herbert Rübben, Boris A. Hadaschik, Kurt Werner Schmid, Bas W.G. van Rhijn, Péter Nyirády & Tibor Szarvas. (2018)
P
athogenic and targetable genetic alterations in 70 urachal adenocarcinomas
. International Journal of Cancer 143:7, pages 1764-1773.
Crossref
Crossref
Yuhong Wang, Shuzhen Zhao, Lihong Zhu, Quanle Zhang & Yanfang Ren. (2018) MiR-19a negatively regulated the expression of PTEN and promoted the growth of ovarian cancer cells. Gene 670, pages 166-173.
Crossref
Crossref
Kai Lin, Hong Jiang, Ling-Ling Zhang, Yi Jiang, Yu-Xian Yang, Guo-Dong Qiu, Yu-Qi She, Jie-Ting Zheng, Chen Chen, Ling Fang & Shu-Yao Zhang. (2018) Down-Regulated LncRNA-HOTAIR Suppressed Colorectal Cancer Cell Proliferation, Invasion, and Migration by Mediating p21. Digestive Diseases and Sciences 63:9, pages 2320-2331.
Crossref
Crossref
Nicole Bäumer, Jan Rehkämper, Neele Appel, Lisa Terheyden, Wolfgang Hartmann, Eva Wardelmann, Frank Buchholz, Carsten Müller-Tidow, Wolfgang E. Berdel & Sebastian Bäumer. (2018) Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth. PLOS ONE 13:7, pages e0200163.
Crossref
Crossref
Hiroya Taniguchi, Yuji Baba, Yoji Sagiya, Masamitsu Gotou, Kazuhide Nakamura, Hiroshi Sawada, Kazunori Yamanaka, Yukiko Sakakibara, Ikuo Mori, Yukiko Hikichi, Junpei Soeda & Hideo Baba. (2018) Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab. Neoplasia 20:7, pages 668-677.
Crossref
Crossref
Marta Schirripa, Stacey A. Cohen, Francesca Battaglin & Heinz-Josef Lenz. (2018) Biomarker-driven and molecular targeted therapies for colorectal cancers. Seminars in Oncology 45:3, pages 124-132.
Crossref
Crossref
Jessica Lüsebrink, Monika Pieper, Ramona-Liza Tillmann, Michael Brockmann, Oliver Schildgen & Verena Schildgen. (2018) Pre-clinical validation of a next generation sequencing testing panel. Experimental and Molecular Pathology 104:3, pages 170-174.
Crossref
Crossref
Giulia Martina Cavestro, Alessandro Mannucci, Raffaella Alessia Zuppardo, Milena Di Leo, Elena Stoffel & Giovanni Tonon. (2018) Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features. Digestive and Liver Disease 50:6, pages 521-532.
Crossref
Crossref
Michele Ghidini, Fausto Petrelli & Gianluca Tomasello. (2018) Right Versus Left Colon Cancer: Resectable and Metastatic Disease. Current Treatment Options in Oncology 19:6.
Crossref
Crossref
José María Sayagués, Sofía Del Carmen, María Del Mar Abad, Luís Antonio Corchete, Oscar Bengoechea, María Fernanda Anduaga, María Jesús Baldeón, Juan Jesús Cruz, Jose Antonio Alcazar, María Angoso, Marcos González, Jacinto García, Luís Muñoz-Bellvis, Alberto Orfao & María Eugenia Sarasquete. (2018)
Combined assessment of the TNM stage and
BRAF
mutational status at diagnosis in sporadic colorectal cancer patients
. Oncotarget 9:35, pages 24081-24096.
Crossref
Crossref
M. Siddiqui, M. Chand, C. Eng, A. Mehdizadeh, A. Mirnezami & G. Brown. (2018) Session 2: Mutational discordance: the big challenge in personalized treatments – any solutions?. Colorectal Disease 20:S1, pages 49-51.
Crossref
Crossref
Tilmann Bochtler, Harald Löffler & Alwin Krämer. (2018) Diagnosis and management of metastatic neoplasms with unknown primary. Seminars in Diagnostic Pathology 35:3, pages 199-206.
Crossref
Crossref
Alexander Lam, Kevin Bui, Eduardo Hernandez Rangel, Michael Nguyentat, Dayantha Fernando, Kari Nelson & Nadine Abi-Jaoudeh. (2018) Radiogenomics and IR. Journal of Vascular and Interventional Radiology 29:5, pages 706-713.
Crossref
Crossref
Antonio Pannuti, Aleksandra Filipovic, Chindo Hicks, Elliot Lefkowitz, Travis Ptacek, Justin Stebbing & Lucio Miele. (2018) Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors. PLOS ONE 13:3, pages e0194790.
Crossref
Crossref
Joanne W. Chiu, Monika K. Krzyzanowska, Stefano Serra, Jennifer J. Knox, Neesha C. Dhani, Helen Mackay, David Hedley, Malcolm Moore, Geoffrey Liu, Ronald L. Burkes, Christine Brezden-Masley, Michael H. Roehrl, Kenneth J. Craddock, Ming-Sound Tsao, Tong Zhang, Celeste Yu, Suzanne Kamel-Reid, Lillian L. Siu, Philippe L. Bedard & Eric X. Chen. (2018) Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience. Clinical Colorectal Cancer 17:1, pages 73-79.
Crossref
Crossref
Ellen G. Engelhardt, Dóra Révész, Hans J. Tamminga, Cornelis J.A. Punt, Mirjam Koopman, Bregje D. Onwuteaka-Philipsen, Ewout W. Steyerberg, Ilse P. Jansma, Henrica C.W. De Vet & Veerle M.H. Coupé. (2018) Clinical Usefulness of Tools to Support Decision-making for Palliative Treatment of Metastatic Colorectal Cancer: A Systematic Review. Clinical Colorectal Cancer 17:1, pages e1-e12.
Crossref
Crossref
Andrew C Nelson, Jamie Boone, David Cartwright, Bharat Thyagarajan, Robyn Kincaid, Aaron P Lambert, Kylene Karnuth, Christine Henzler & Sophia Yohe. (2017) Optimal detection of clinically relevant mutations in colorectal carcinoma: sample pooling overcomes intra-tumoral heterogeneity. Modern Pathology 31:2, pages 343-349.
Crossref
Crossref
Jing-Hua Kuai, Qing Wang, Ai-Jun Zhang, Jing-Yu Zhang, Zheng-Feng Chen, Kang-Kang Wu & Xiao-Zhen Hu. (2018) Epidermal growth factor receptor-targeted immune magnetic liposomes capture circulating colorectal tumor cells efficiently. World Journal of Gastroenterology 24:3, pages 351-359.
Crossref
Crossref
Pawel Sadlecki, Dariusz Grzanka & Marek Grabiec. (2018)
Testing for
NRAS
Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
. Disease Markers 2018, pages 1-7.
Crossref
Crossref
Veena Shankaran, Jesse D. Ortendahl, Anna G. Purdum, Bjorn Bolinder, Ayanna M. Anene, Gordon H. Sun & Tanya G.K. Bentley. (2018) Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States. American Journal of Clinical Oncology 41:1, pages 65-72.
Crossref
Crossref
A.R. Parikh & R.B. Corcoran. (2018) Monitoring resistance through liquid biopsy. Annals of Oncology 29:1, pages 8-11.
Crossref
Crossref
Nele Boeckx, Katleen Janssens, Guy Van Camp, Marika Rasschaert, Konstantinos Papadimitriou, Marc Peeters & Ken Op de Beeck. (2018) The predictive value of primary tumor location in patients with metastatic colorectal cancer: A systematic review. Critical Reviews in Oncology/Hematology 121, pages 1-10.
Crossref
Crossref
Lula Smith, Samuel Anti, Natalie White & Sabita N. Saldanha. 2018. Epigenetic Mechanisms in Cancer. Epigenetic Mechanisms in Cancer
87
115
.
Allyson E. Koyen, Geraldine Nabeta, Stevin Bienfait, Ashley J. Schlafstein, David S. Yu & Waaqo Daddacha. 2018. Role of Tyrosine Kinases in Gastrointestinal Malignancies. Role of Tyrosine Kinases in Gastrointestinal Malignancies
225
234
.
Marta Martins, André Mansinho, Raquel Cruz-Duarte, Soraia Lobo Martins & Luís Costa. 2018. Targeted Therapy of Colorectal Cancer Subtypes. Targeted Therapy of Colorectal Cancer Subtypes
113
131
.
Maria Sofia Fernandes, João Miguel Sanches & Raquel Seruca. 2018. Targeted Therapy of Colorectal Cancer Subtypes. Targeted Therapy of Colorectal Cancer Subtypes
35
53
.
Yuping Zhu, Bo Li, Zhuo Liu, Lai Jiang, Gang Wang, Min Lv & Dechuan Li. (2017) Up-regulation of lncRNA SNHG1 indicates poor prognosis and promotes cell proliferation and metastasis of colorectal cancer by activation of the Wnt/β-catenin signaling pathway. Oncotarget 8:67, pages 111715-111727.
Crossref
Crossref
Helei Hou, Dong Liu, Chuantao Zhang, Yanxia Jiang, Guifang Lu, Na Zhou, Xiaonan Yang, Xiaoping Zhang, Zhuokun Li, Hongmei Zhu, Zhaoyang Qian & Xiaochun Zhang. (2017) Targeted next generation sequencing in Chinese colorectal cancer patients guided anti-EGFR treatment and facilitated precision cancer medicine. Oncotarget 8:62, pages 105072-105080.
Crossref
Crossref
Maxim Ivanov, Konstantin Laktionov, Valery Breder, Polina Chernenko, Ekaterina Novikova, Ekaterina Telysheva, Sergey Musienko, Ancha Baranova & Vladislav Mileyko. (2017) Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions. Journal of Translational Medicine 15:1.
Crossref
Crossref
Weihua Li, Tian Qiu, Lei Guo & Jianming Ying. (2017) Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing. Cancer Letters 410, pages 92-99.
Crossref
Crossref
Yuji Miyamoto, Wu Zhang & Heinz-Josef Lenz. (2016) Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer. Indian Journal of Surgical Oncology 8:4, pages 580-590.
Crossref
Crossref
Agata Olejniczak, Magdalena Szaryńska & Zbigniew Kmieć. (2017) In vitro characterization of spheres derived from colorectal cancer cell lines. International Journal of Oncology.
Crossref
Crossref
Karen-Lise G. Spindler, Anders K. Boysen, Niels Pallisgård, Julia S. Johansen, Josep Tabernero, Morten M. Sørensen, Benny V. Jensen, Torben F. Hansen, David Sefrioui, Rikke F. Andersen, Ivan Brandslund & Anders Jakobsen. (2017) Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. The Oncologist 22:9, pages 1049-1055.
Crossref
Crossref
Alain R. Thierry, Brice Pastor, Zhi-Qin Jiang, Anastasia D. Katsiampoura, Christine Parseghian, Jonathan M. Loree, Michael J. Overman, Cynthia Sanchez, Safia El Messaoudi, Marc Ychou & Scott Kopetz. (2017) Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer. Clinical Cancer Research 23:16, pages 4578-4591.
Crossref
Crossref
Jian-Ming Xu, Yan Wang, You-Liang Wang, Yan Wang, Tao Liu, Ming Ni, Man-Sheng Li, Li Lin, Fei-Jiao Ge, Chun Gong, Jun-Yan Gu, Ru Jia, He-Fei Wang, Yu-Ling Chen, Rong-Rui Liu, Chuan-Hua Zhao, Zhao-Li Tan, Yang Jin, Yun-Ping Zhu, Shuji Ogino & Zhi-Rong Qian. (2017)
PIK3CA
Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
. Clinical Cancer Research 23:16, pages 4602-4616.
Crossref
Crossref
Lu-Bing Liu, Tong Liu & Fu-Ze Xin. (2017) Correlations of ICAM-1 gene polymorphisms with susceptibility and multidrug resistance in colorectal cancer in a Chinese population. Medicine 96:33, pages e7481.
Crossref
Crossref
Maria Thomsen, Marianne Grønlie Guren, Eva Skovlund, Bengt Glimelius, Marianne Jensen Hjermstad, Julia S. Johansen, Elin Kure, Halfdan Sorbye, Per Pfeiffer, Thoralf Christoffersen, Tormod Kyrre Guren & Kjell Magne Tveit. (2017) Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status. European Journal of Cancer 81, pages 26-35.
Crossref
Crossref
Displaying 200 of 272 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list